Risedronate as a therapeutic trial post-hysterectomy in premenopausal women to prevent osteoporosis
Ban Hadi Hameed
مجله كليه طب الكندي · 2018
doi:10.47723/kcmj.v14i1.6 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Background: Osteoporosis is a skeletal defect manifested by a reduction of bone strength as a result of reduced bone mass to the extent that there is a higher risk of fracture even on minor trauma. Hysterectomy in a premenopausal woman is a well known cause of ovarian failure resulting in an increased risk of osteoporosis. Objective: To clarify bisphosphonate's preventive effect on osteopenia and osteoporosis in premenopausal women after hysterectomy. Type of the study: Cross –sectional study. Method: 84 premenopausal females post hysterectomy aged between 40 – 50 years, were enrolled in this randomized controlled double blinded trail at Al Yarmouk teaching hospital and private clinic in Baghdad for a period of two years from Augest 2011 till July 2013. Participants were assigned as: 1stgroup (study group 42 women): received risedronate treatment "over a period of one year" with calcium and vitamin D; and 2ndgroup (control group 42 women) were taken as a matched group for:"age, body mass index (BMI) and fracture history", received only calcium and vitamin D as a placebo. Bone density had been assayed at the end of the year for all participants and evaluated for osteopenia and osteoporosis. Results: Osteopenia and osteoporosis were significantly lower in the risedronate arm as compared to those not received the drug "14.3% & 11.9% versus 26.1% & 19% respectively". Conclusion: The bone mineral density results were significantly better in those who received risedronate than those not received the drug.
Abstract licence: CC BY
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.